Publications:

Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas.

Nature Communications

Paik, Paul K PK; Luo, Jia J; Ai, Ni N; Kim, Rachel R; Ahn, Linda L; Biswas, Anup A; Coker, Courtney C; Ma, Wanchao W; Wong, Phillip P; Buonocore, Darren J DJ; Lai, W Victoria WV; Chaft, Jamie E JE; Acharyya, Swarnali S; Massagué, Joan J; Kris, Mark G MG

Publication Date: 2022-10-15

Variant appearance in text: TP53: 1142A>C

PubMed Link: 36241629

Variant Present in the following documents:

• 41467_2022_33719_MOESM1_ESM.pdf

View BVdb publication page

iFish: predicting the pathogenicity of human nonsynonymous variants using gene-specific/family-specific attributes and classifiers.

Scientific Reports

Wang, Meng M; Wei, Liping L

Publication Date: 2016-08-16

Variant appearance in text: TP53: K381T

PubMed Link: 27527004

Variant Present in the following documents:

• srep31321-s5.xls, sheet 1

View BVdb publication page

Impaired p53 binding to importin: a novel mechanism of cytoplasmic sequestration identified in oxaliplatin-resistant cells.

Oncogene

Komlodi-Pasztor, E E; Trostel, S S; Sackett, D D; Poruchynsky, M M; Fojo, T T

Publication Date: 2009-09-03

Variant appearance in text: p53: K381T

PubMed Link: 19581934

Variant Present in the following documents:

• Main text

View BVdb publication page